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Abstract 20 
Pyflubumide is a novel selective carboxanilide acaricide that inhibits mitochondrial complex II of 21 
mainly spider species such as Tetranychus urticae. We explored the baseline toxicity and potential cross-22 
resistance risk of pyflubumide in a reference panel of T. urticae strains resistant to various acaricides 23 
with different modes of action. A cyenopyrafen resistant strain (JPR) was identified as the only strain 24 
with low-to-moderate level of cross-resistance to pyflubumide (LC50 = 49.07 mg/L). In a resistance risk 25 
assessment approach, JPR was subsequently selected which lead to two highly resistant strains JPR-R1 26 
(LC50 = 1437.48 mg/L) and JPR-R2 (LC50 = 1893.67 mg/L). Interestingly, compared to adult females, 27 
resistance was much less pronounced in adult males and eggs of the two JPR-R strains. In order to 28 
elucidate resistance mechanisms, we first sequenced complex II subunits in susceptible and resistant 29 
strains, but target-site insensitivity could not be detected. In contrast, synergism/ antagonism 30 
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experiments strongly suggested that cytochrome P450 monooxygenases are involved in pyflubumide 31 
resistance. We therefore conducted genome-wide gene expression experiments to investigate 32 
constitutive and induced expression patterns and documented the overexpression of five cytochrome 33 
P450 and four CCE genes in JPR-Rs after pyflubumide exposure. Together, we provide a thorough 34 
resistance risk assessment of a novel complex II inhibitor, and provide first evidence for metabolic 35 
resistance mediated by cytochrome P450s in T. urticae.  36 
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Key message 39 
• This study provides a thorough resistance risk assessment of the novel mitochondrial complex 40 
II inhibitor pyflubumide in Tetranychus urticae.  41 
• We identified a low-to-moderate level of cross-resistance to pyflubumide in the cyenopyrafen 42 
resistant strain JPR. 43 
• Under pyflubumide selection pressure, JPR rapidly evolved high level resistance, but only in 44 
females. 45 
• Target-site insensitivity could not be detected in the resistant strains.  46 
• Synergism/antagonism experiments followed by genome-wide gene expression experiments 47 
strongly suggest that cytochrome P450 monooxygenases are involved in pyflubumide 48 
resistance.  49 
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Introduction 54 
The two-spotted spider mite, Tetranychus urticae Koch (Arthropoda: Chelicerata: Acariformes) is an 55 
important cosmopolitan agricultural pest that causes significant yield losses in the absence of a proper 56 
pest and resistance management strategy (Jeppson et al. 1975; Van Leeuwen et al. 2015). The application 57 
of acaricides still remains the most frequently used method to keep T. urticae populations below 58 
economic thresholds for many crops. However, the fast development of resistance in the species, in part 59 
due to biological characteristics such as a short life cycle, high reproductive potential, arrhenotokous 60 
reproduction, together with a broad host plant range, reduces the efficacy of the application of acaricides 61 
(Dermauw et al. 2013; Van Leeuwen et al. 2010; Wybouw et al. 2019). It is therefore important to 62 
continue to develop acaricides with new modes of action and limited cross-resistance to other 63 
commercially available compounds to secure proper resistance management in T. urticae (Nauen et al. 64 
2012; Van Leeuwen, Thomas et al. 2015; Fotoukkiaii et al. 2019). The carboxanilide pyflubumide is a 65 
recently developed acaricide by Nihon Nohyaku Co. Ltd with excellent activity against phytophagous 66 
mites of the genus Tetranychus and Panonychus (both belong to the Tetranychidae family) (Nakano et 67 
al. 2015). Pyflubumide is structurally similar to the carboxamide fungicides that inhibit succinate-68 
dehydrogenase. Pyflubumide, together with the beta-ketonitriles cyenopyrafen and cyflumetofen, are 69 
the first commercially developed acaricides that act as complex II inhibitors in the mitochondrial 70 
electron transport chain (Furuya et al. 2017; Van Leeuwen et al. 2015). Similar to the beta-ketonitriles, 71 
pyflubumide is a pro-acaricide that is converted to a more potent de-acylated metabolite (Nakano et al. 72 
2015). Although the metabolites of pyflubumide and cyenopyrafen are reported to both strongly inhibit 73 
complex II, different binding modes have been suggested with the target-site (Furuya et al. 2015; 74 
Nakano et al. 2015). Cross-resistance to conventional acaricides in Japanese field collected resistant 75 
populations was not detected for pyflubumide (Furuya et al. 2015). The specificity of pyflubumide and 76 
its compatibility with non-target arthropods such as pollinators and natural enemies make it an ideal 77 
candidate for integrated pest management (IPM) programs (Furuya et al. 2017; Van Leeuwen et al. 78 
2015).  79 
In this study, the baseline activity and potential cross-resistance risk of pyflubumide was explored by 80 
analyzing its toxicity in a reference panel of T. urticae strains resistant to various acaricides with 81 
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different modes of action. The base line toxicity on adult females, males, and eggs of resistant and 82 
susceptible mites was also assessed. Our survey identified a strain resistant to cyenopyrafen (JPR) as 83 
the only strain with a low-to-moderate level of cross-resistance to pyflubumide. We subsequently 84 
selected JPR for higher levels of pyflubumide resistance and finally obtained two highly resistant strains. 85 
To gain further insight into the molecular mechanisms that underpin pyflubumide resistance, we 86 
screened for potential target-site resistance mutations, conducted synergism/antagonism experiments, 87 
and analyzed transcriptomic changes under various conditions between susceptible and resistant strains.  88 
 89 
Materials and methods 90 
Survey of pyflubumide resistance  91 
A reference panel of fifteen acaricide-susceptible and -resistant T. urticae strains (Table 1) were 92 
screened for resistance to pyflubumide in toxicity bioassays on adult female mites as described below. 93 
All strains were maintained on potted bean plants Phaseolus vulgaris L. cv. ‘‘Speedy’’ at 25 ± 1°C, 60% 94 
RH, and 16:8 h (L:D) photoperiod. Commercial formulations (20% SC, Danikong) of pyflubumide was 95 
kindly provided by Ralf Nauen. All other chemicals and synergists were analytical grade and purchased 96 
from Sigma-Aldrich. 97 
Selection for pyflubumide resistance 98 
To assess the risk of the development of pyflubumide resistance in T. urticae, JPR was reared with 99 
pyflubumide selection pressure under two different laboratory regimes, as described below. The two 100 
derived strains are referred to as JPR-R1 and JPR-R2. 101 
1) Plate selection regime 102 
Approximately 2000 adult female JPR mites were placed on four detached bean leaves in separate Petri 103 
dishes (about 500 females per leaf). Mites were sprayed with 1 ml of 100 mg/L pyflubumide (~ LC90 104 
of JPR) using a Potter spray tower resulting in 2 mg aqueous deposit per cm2. After 48 h, females that 105 
appeared unaffected were transferred to untreated bean plants and allowed to propagate for 106 
approximately three generations. The dose-response relationship of pyflubumide toxicity was assessed 107 
in this generation, hereafter called SEL1. A second round of selection was undertaken with 1000 mg/L 108 
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pyflubumide using the same approach, resulting in generation SEL2. From generation SEL2 onwards, 109 
the population was grown on bean plants sprayed until run off with 100 mg/L. The resulting resistant 110 
strain was named JPR-R1. 111 
2) On plant selection regime 112 
Approximately 2000 adult female JPR mites were transferred to potted bean plants that were sprayed 113 
with a hand-hold spraying device with 100 mg/L pyflubumide until run-off. Before spraying, plant buds 114 
were removed and only the primary leaves were kept on the potted bean plants. After seven days, all 115 
apparent unaffected mites (from all stages and both sexes) were collected and transferred to untreated 116 
bean plants for propagation. The strain was named JPR-R2 and maintained on potted bean plants with a 117 
constant selection pressure of 100 mg/L of pyflubumide until analysis. 118 
Toxicity bioassays  119 
Bioassays were performed on eggs, adult females and males. To obtain eggs of a synchronized age for 120 
egg bioassays, 50-60 adult females were placed on the upper side of 9 cm2 bean leaf discs and allowed 121 
to oviposit for 4 h. After removing adult mites, the number of eggs were counted per petri dish. After 122 
24 h, the eggs were sprayed with 1 mL of spray fluid at 1 bar pressure in the Potter spray tower, resulting 123 
in 2 mg aquous deposit per cm2. Four replicates of five-eight concentrations of pyflubumide and a 124 
control (deionized water) were tested. Mortality was scored after 5 days. Percentage of mortality was 125 
calculated by dividing the number of hatched larvae to the number of eggs.  126 
Female and male bioassays were conducted using a standardized method previously described by (Van 127 
Leeuwen et al. 2006). Briefly, we tested five-eight concentrations in four replicates. For each replicate 128 
20-30 adults were transferred to 9 cm2 bean leaf discs on wet cotton wool. Leaf discs were sprayed as 129 
outlined above, and mortality was scored after 24 h.  130 
LC50-values and the 95% confidence limits were calculated from probit regressions using the POLO-131 
Plus software (LeOra Software, 2006). 132 
Sequencing of SQR subunits 133 
DNA extraction of the JPR and JPR-R populations was performed as described by Van Leeuwen (2008) 134 
(Van Leeuwen et al. 2008). Briefly, approximately 200 adult females were collected and homogenized 135 
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in 800 μL SDS buffer (200mM Tris-HCl, 400 mM NaCl, 10 mM EDTA, 2% SDS at pH = 8.3) followed 136 
by a phenol-chloroform extraction. The four subunits of JPR-R2 and JPR strains were sequenced using 137 
the primer pairs listed in supplemental file 1. PCR reactions were conducted in 50 μL of reaction mixture 138 
containing 2 mM of MgCl2, 0.2 μM of each primer, 0.2 mM of deoxynucleotide triphosphate (dNTP) 139 
mix (Invitrogen, Merelbeke, Belgium), 5 μL of 10× PCR-buffer (Invitrogen) and 1U of Taq DNA 140 
polymerase (Invitrogen), under the following conditions: 2 min at 95 °C, 35 cycles of 15 s at 95 °C, 30 141 
s at 55 °C and 30 s at 72 °C, and a final extension of 2 min at 72 °C. After purification using E.Z.N.A. 142 
Cycle-Pure kit (Omega Bio-tek, Norcross, GA, USA), PCR products were sequenced at LGC Genomics 143 
(Germany). All SQR subunits of JPR-R2 and JPR were screened for nucleotide variants using those of 144 
the London strain as reference. 145 
Synergism/antagonism and barbital experiments 146 
Synergism/antagonism experiments were performed according to the methods described by Van 147 
Pottelberge et al. (2009). Briefly, 1,000 mg/L of piperonyl butoxide (PBO), 500 mg/L of S,S,S-tributyl 148 
phosphorotrithioate (DEF) and 2,000 mg/L of diethylmaleate (DEM) were used as the final 149 
concentrations in the experiments. The synergists/antagonists were first dissolved in N, N dimethyl 150 
formamide and emulsifier W (3:1), and then diluted to the respective concentrations 151 
using deionized water. Mites were sprayed with 1 ml of the synergist/antagonist solution as described 152 
above. Exactly 24 h after synergist treatment, mites were used in pyflubumide bioassays. Mortality was 153 
recorded after 24 h and synergism ratios (SR) were determined by dividing the LC50 of pyflubumide 154 
alone by the LC50 obtained after synergist pre-treatment. 155 
For barbital assays, the methods described by (Van Pottelberge et al. 2008) were followed. In short, the 156 
barbital solution was made by dissolving barbital powder in deionized water. Each replicate (20-30 adult 157 
females) was sprayed with 1 ml of 10,000 mg/L barbital solution as described above. After 4 h, mites 158 
were sprayed with five-eight concentrations of pyflubumide and a control each with four replicates. The 159 
synergism/antagonism ratio was determined by dividing the LC50 of treated population by the LC50 of 160 
non-treated population. 161 
 Timing of symptomology  162 
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To determine the timing of symptomology, we used 100 mg/L pyflubumide which is a concentration 163 
that did not lead to physiological symptoms in JPR-R1 and JPR-R2 strains. About 30 adult female mites 164 
from strains JPR, JPR-R1, and JPR-R2 were transferred to the upper side of 9 cm2 bean leaf discs in ten 165 
replicates. All 30 petri dishes were sprayed with 100 mg/L of pyflubumide using the Potter spray tower 166 
as described above. Four replicates were sprayed with deionized water as a control. All plates were 167 
checked every 1.5 h, starting 1h into the photophase, until the18 h timepoint, with a final observation at 168 
24 h. Dead mites and mites that proved unable to walk the length of their body or displayed 169 
uncoordinated behavior (spastic movement) after a gentle touch by a tiny brush were recorded as 170 
affected. Significant differences in the percentage of affected mites across time points were determined 171 
using a General Linear Model (GLM) followed by Tukey's HSD tests (α = 0.05). Statistical analysis was 172 
conducted within the R framework [R Core Team (2014), version 3.1.2] (Team 2018).The experiment 173 
was conducted at 23-25 °C, 60% RH, and 18/6h (L/D) photoperiod with the photophase started at 6:00 174 
AM. 175 
Experimental set-ups for the transcriptomic analyses of pyflubumide resistance 176 
Three transcriptomic experiments were performed that differed in the way T. urticae strains were 177 
exposed to pyflubumide. First, four RNA samples were collected from JPO (the ancestral strain of JPR) 178 
(Sugimoto and Osakabe 2014), JPR, JPR-R1, and JPR-R2 that were maintained for one generation on 179 
non-sprayed plants. Next, four samples were collected from JPR and JPR-R1 that were either exposed 180 
to pyflubumide or deionized water for 9 h. Here, approximately 500 adult female mites were placed on 181 
detached leaf discs on wet cotton wool and were sprayed with 1 ml of pyflubumide solution (100 mg/L) 182 
or deionized water at 1 bar pressure in a Potter spray tower resulting in 2 mg aqueous deposit per cm2. 183 
Last, four RNA samples were collected from JPR-R1 and JPR-R2 that were either sprayed with 184 
pyflubumide (100 mg/L) or deionized water 24 h before collection, using the same methodology as for 185 
the 9h time point. 186 
RNA extraction and transcriptomic analyses of pyflubumide resistance 187 
Per sample, RNA was extracted from a bulk of 120-150 adult females using a RNeasy minikit (Qiagen), 188 
treated with DNase (Turbo, Ambion), and labelled using the Low Input Quick Amplification Kit 189 
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(Agilent Technologies). RNA samples were dyed with cyanine-3 or cyanine-5. Cyanine-labeled RNA 190 
was hybridized in the respective mixes (cyanine-5 and cyanine-3) to a custom Agilent GE microarray 191 
(Gene Expression Omnibus (GEO) Platform GPL16890). After washing using the Gene Expression 192 
Wash Buffer kit (Agilent Technologies), microarray slides were scanned with an Agilent Microarray 193 
High-Resolution Scanner. The raw intensity values are accessible at the GEO website (GSE138192) and 194 
were used for statistical analysis in limma (Smyth Gordon 2004). Background correction was performed 195 
using the ‘normexp’ method (with an offset of 50) (Ritchie et al. 2007). Within- and between-array 196 
normalization was applied using the global loess and Aquantile methods, respectively. Data quality was 197 
assessed at every step using arrayQualityMetrics (Kauffmann et al. 2008).  Using the probe annotation 198 
identified in (Snoeck et al. 2018), a linear model was fitted to the processed data, incorporating intraspot 199 
correlations (Smyth and Altman 2013). Significant differential gene-expression was identified by 200 
empirical Bayesian statistics with cut-offs of Benjamini-Hochberg corrected p-values and log2FC at 0.05 201 
and 1, respectively. A Principal Component Analysis (PCA) was performed on relative transcription 202 
levels using the prcomp function within the R environment (Team 2018). An optimal number of clusters 203 
for k-means clustering was assessed using the gap statistic (global max, seed number set at 54321, cluster 204 
number ranging from 2 to 10) (Tibshirani et al. 2001). Using JPO as a common reference, the relative 205 
gene-expression levels of genes that were significantly differentially expressed in any comparison were 206 
used as input and clustered using the centered Pearson’s correlation as distance metric.     207 
Results 208 
Pyflubumide cross-resistance screen and selection 209 
The toxicity of pyflubumide in a number of laboratory and field-collected T. urticae strains is shown in 210 
Table 1. All strains displayed similar LC50 values (2-7 mg/ L), with the exception of JPR, that exhibited 211 
an LC50 value of 49 (37.62 - 65.63) mg/ L.  212 
To assess the risk of resistance development, JPR was selected for pyflubumide resistance using two 213 
different selection regimes. After selection with 100 mg/L on plates, the resulting population SEL1 214 
displayed an LC50 value of 247.78 (190.58 - 303.23) mg/L. A second selection with 1,000 mg/L resulted 215 
in population SEL2 with LC50 of 824.96 (693.47 to 966.43) mg/L. The population was further 216 
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maintained on sprayed plants with 100 mg/L and the LC50 of the final population, JPR-R1, was 1,437.48 217 
(1,221.26 – 1,666.77) mg/L (Fig. 1). 218 
In an alternative approach, the strain JPR was independently selected for pyflubumide resistance on 219 
potted plants, and resulted in the JPR-R2 strain, with an LC50 value of 1,893.67 (1,641.63 – 2,156.25) 220 
mg/ L.  221 
Toxicity of pyflubumide on females, males, and eggs of susceptible and resistant mites 222 
The LC50 values of pyflubumide on females, males and eggs of Wasatch, JPR, JPR-R1 and JPR-R2 223 
strains are reported in Table 2. Pyflubumide was toxic to all tested stages of Wasatch, but males were 224 
about 10-fold more susceptible, while eggs were clearly less susceptible (Table 2). While resistance 225 
levels were high in adults in both JPR-R strains, eggs showed a marked higher susceptibility (54.10 and 226 
98.19 mg/ L) to pyflubumide, and resistance levels were also lower in males. In contrast, resistance 227 
levels in parental JPR were low in adults (49 mg/L) and higher in eggs (318 mg/L), a pattern that was 228 
apparently not maintained, nor fortified by selection for pyflubumide resistance. 229 
Sequencing of the succinate: ubiquinone oxidoreductase subunits 230 
Only synonymous SNPs were identified in tetur01g15710 (SdhB), tetur30g00210 (SdhC) and 231 
tetur20g00790 (SdhD). In tetur08g03210 (SdhA), we found a substitution V209I between the London 232 
sequence (V209) and both JPR (I209) and JPR-R2 (I209). Coding sequences generated in this study are 233 
accessible at the NCBI repository (XXXX). 234 
Synergism and antagonism assays  235 
The effect of synergists PBO, DEF and DEM on pyflubumide toxicity are presented in Table 3. 236 
Synergism/antagonism assays were performed on susceptible LS-VL, JPR, JPR-R1 and JPR-R2. 237 
Pyflubumide toxicity was synergized two-fold by PBO in JPR and much higher in JPR-R1 and JPR-R2 238 
with remarkable SRs of 15- and 20-fold, respectively. DEF antagonized pyflubumide toxicity in all 239 
strains, however, the antagonism was about 10-fold higher in JPR. The synergistic effects with DEM 240 
was higher in JPR-R1 and JPR-R2 compared with JPR (Table 3). The results of phenobarbital effect on 241 
toxicity of pyflubumide are presented in Table 4. Barbital treatment decreased the toxicity of 242 
pyflubumide more in JPR-R1 and JPR-R2, as compared with JPR (Table 4). 243 
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Constitutive transcriptomic changes associated with selection for pyflubumide resistance  244 
To characterize potential constitutive, or environmentally independent, transcriptomic changes 245 
associated with selection for pyflubumide resistance, the transcriptomes were sampled of JPO, JPR, 246 
JPR-R1, and JPR-R2, all maintained for one generation without selection pressure on non-sprayed bean 247 
plants. A PCA shows that the transcriptomic profile of JPO was highly divergent from JPR and JPR-248 
R1-2 and that a low percentage of the total data variation underlined the differences between JPR and 249 
JPR-R1-2 (Fig. 2A). Using JPR as the parental reference, a small number of genes were significantly 250 
differentially transcribed in JPR-R1 and JPR-R2 (47 and 37, respectively) (Fig. 2B and Supplemental 251 
file 2). Of these, only 14 genes were consistently differentially expressed in both JPR-R1 and JPR-R2. 252 
Three genes (tetur13g01730, tetur14g03160, and tetur14g01700) were consistently up-regulated upon 253 
pyflubumide selection, but none coded for enzymes that are known to be associated with xenobiotic 254 
metabolism (hypothetical proteins and a protein with an ‘Immunoglobulin E-set’ domain (IPR014756), 255 
respectively) (Fig. 2B and Supplemental file 2). One of the genes with a lower transcription level in 256 
JPR-R1 and JPR-R2, tetur03g00830, coded for the cytochrome P450 CYP392A12 (Fig. 2B). No 257 
carboxyl/cholinesterase (CCE) genes were down-regulated in these two comparisons. We hypothesized 258 
that the transcriptomic signature of pyflubumide resistance might have been masked in these 259 
comparisons because it was already present in the ancestral, cross-resistant JPR strain. Therefore, as a 260 
next step, we used the original and susceptible JPO strain (the parent of JPR) as a reference to look at 261 
transcriptomic changes. Compared to JPO, 454 genes were differentially expressed in JPR, whereas 362 262 
and 368 differentially expressed genes (DEGs) were detected in JPR-R1 and JPR-R2, respectively 263 
(Supplemental Tables). Selecting JPR from JPO was associated with the up-regulation of 16 cytochrome 264 
P450 genes, with CYP392D2, CYP392D6, and CYP392A12 having a log2FC higher than four. Two CCE 265 
genes (tetur17g00360 and tetur30g01290) were down-regulated in JPR compared to JPO, whereas six 266 
CCE genes showed a significant up-regulation. In both JPR-R1 and JPR-R2, 13 cytochrome P450s were 267 
up-regulated compared to JPO, of which 11 genes already showed significant up-regulation in JPR 268 
(CYP392D2, CYP392D6, and CYP392E8 had the highest average transcriptional increase 269 
(Supplementary Tables)). JPR-R1 and JPR-R2 each had one unique up-regulated cytochrome P450 270 
(tetur03g05040 and tetur06g02620, respectively (both are not full-length in the reference London 271 
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genome (Grbić et al. 2011))). Tetur03g05010 was the only cytochrome P450 (CYP392D4) that was up-272 
regulated in JPR-R1-2, but not in JPR (average log2FC of 1.02). Only JPR-R1 had a down-regulated 273 
CCE gene that was not already down-regulated in JPR; tetur01g10800 with a log2FC of -1.08. To gain 274 
more insight into the transcriptional evolution of these and other genes, all 560 DEGs were grouped 275 
using k-means clustering, and three distinct transcriptional patterns became apparent (Fig. 2C and 276 
Supplemental Tables). The 513 DEGs of cluster 1 and 2 showed a stable down- and up-regulation, 277 
respectively, across JPR, JPR-R1, and JPR-R2. The 47 DEGs of cluster 3 showed a high relative 278 
transcription level in JPR-R1-2, but not in JPR. Notably, CYP392D4 was placed in this group of DEGs. 279 
Symptomology timing 280 
In order to gain insights in the time of toxicity in relation to potential plastic transcriptional changes, 281 
mites were exposed to pyflubumide and cumulative percentages of mortality and symptoms were 282 
followed during 24 h after spraying with a sub-lethal dose of pyflubumide in JPR and JPR-R1-2 (Fig. 283 
3). The highest level of pyflubumide-induced toxicity symptoms was observed nine hours after spraying 284 
in both JPR-R1 (df = 2; F = 7.90; P = 0.0019) and JPR-R2 (df = 2; F = 12.63; P < 0.0001). The symptom 285 
level at this time point was significantly different from that of the previous time points, i.e., 7.5 h 286 
(Tukey’s post hoc test, P < 0.001 for both JPR-R1 and JPR-R2) and the next time point at 10.5 h 287 
(Tukey’s post hoc test, P = 0.038 and P = 0.037  for JPR-R1 and JPR-R2, respectively). After 9 h the 288 
symptoms declined in JPR-R1-2, whereas JPR showed an increase in the level of symptoms (Fig. 3). 289 
Plastic transcriptomic responses to pyflubumide exposure 290 
As only limited constitutive gene expression differences were observed between JPR and JPR-R1-2, the 291 
plastic, environmentally dependent, transcriptomic changes were also characterized to shed more light 292 
on the molecular basis of pyflubumide resistance. Based on the symptomology bioassays, we first 293 
investigated the transcriptomic responses of JPR and JPR-R1 after nine hours of exposure to a sub-lethal 294 
dose of pyflubumide (100 mg/L). Here, no DEGs were detected in JPR-R1 upon pyflubumide exposure, 295 
whereas a single DEG (tetur04g04350, log2FC of 1.17) was observed in JPR. Next, we focused on the 296 
plastic responses of JPR-R1-2 upon 24 h of exposure to the same sub-lethal dose of pyflubumide, versus 297 
water-sprayed controls. As reflected in the PCA (alongside the PC1 axis, Fig. 4A), large transcriptomic 298 
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changes were observed here, clearly separating water-sprayed from pyflubumide-sprayed populations. 299 
Using water-sprayed populations as respective references, JPR-R1 had 294 DEGs, whereas JPR-R2 300 
exhibited 118 DEGs (Fig. 4B). Over 92% of the transcriptional response of JPR-R2 was also present in 301 
the response of JPR-R1, and the shared DEGs (n=109) exhibited a positive relationship in their plastic 302 
transcriptional response (Fig. 4B). Eight cytochrome P450s were part of this positively correlated 303 
response, of which five showed up-regulation after exposure to pyflubumide (Fig. 4B). Four CCE genes 304 
were up-regulated when the resistant strains were exposed to pyflubumide (Supplementary Tables). 305 
Discussion 306 
The development of new acaricides with new modes of action and limited cross-resistance to other 307 
conventional compounds remains crucial for efficient resistance management of phytophagous mite 308 
pests like T. urticae (Nauen et al. 2012). Pyflubumide is a newly developed complex II inhibitor and the 309 
first acaricide with a carboxanilide structure (Furuya et al. 2017). In this study, the compound proved to 310 
be very active on a collection of strains with varying levels of resistance to commercially available 311 
compounds. However, we uncovered decreased susceptibility in a Japanese strain named JPR, which 312 
was selected out of JPO with cyenopyrafen (Sugimoto and Osakabe 2014). The decreased pyflubumide 313 
susceptibility was only found in JPR, and not its parent JPO, suggesting that selection for cyenopyrafen 314 
resistance resulted in decreased susceptibility for pyflubumide (Table 1), a typical case of moderate 315 
cross-resistance. As cyenopyrafen and pyflubumide both belong to complex II inhibitors acaricides and 316 
their active metabolites act on the same enzyme (Nakano et al. 2015), cross-resistance is not surprising, 317 
although pyflubumide and cyenopyrafen belong to different chemical families, and might have slight 318 
different binding modes (Nakano et al. 2015). In addition, cross-resistance between cyenopyrafen and 319 
cyflumetofen, both beta-ketonitriles, has been demonstrated in JPR (Khalighi et al. 2016).   320 
Before studying the mechanisms of (cross)-resistance, we attempted to further fix pyflubumide 321 
resistance in JPR using two different laboratory selection regimes, and obtained two highly resistant 322 
strains, JPR-R1 and JPR-R2. Pyflubumide resistance evolved very quickly (Fig. 1), indicating that under 323 
field conditions pyflubumide efficacy would be at risk after prior selection with cyenopyrafen. 324 
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In the susceptible Wasatch strain, males were much more susceptible to pyflubumide than females, while 325 
in contrast, eggs were much less susceptible. Variation in pesticide susceptibility between sexes and 326 
developmental stages of pest species can be related to morphological differences (e.g. body size or egg 327 
shell thickness) and/or metabolic differences (e.g. differential expression of detoxifying enzymes). A 328 
smaller male and egg size in T. urticae can provide a higher exposure to acaricides through higher 329 
surface-to-volume ratios, although sexual size dimorphism is not always related to variation in pesticide 330 
tolerance (Daly and Fitt 1990; Rathman et al. 1992). When assessing stage-specific effects of 331 
pyflubumide resistance, we discovered that unlike adult females, males and eggs of the two JPR-R 332 
strains were still highly susceptible to pyflubumide, so resistance was strongly female biased. This 333 
pattern was however not observed for JPR where eggs retained most of the resistance levels (Table 2). 334 
As resistance levels were maintained in eggs versus adults in JPR, but not in JPR-R, this would suggest 335 
that at least additional mechanisms were selected. Stage specific effects in resistance has been previously 336 
reported in spider mites; spirodiclofen resistance is high in adult T. urticae females but absent in eggs 337 
(Van Pottelberge, Van Leeuwen, Khajehali et al. 2009). Sex-linked pesticide resistance has been 338 
observed in haplodiploid species such as spider mites where unfertilized haploid eggs develop into males 339 
and fertilization leads to diploid females (Carrière 2003). One of the underlying mechanisms might be 340 
a dosage-effect of the resistance alleles in haploid males (Carrière 2003). This mechanism is similar to 341 
sex-linked pesticide resistance in diplodiploid species in which the sex-linked allele is not always 342 
present, or expressed in a specific gender (Baker et al. 1994; Marín et al. 2000; Rao and Padmaja 1992). 343 
Of practical importance, the effectiveness of resistance management strategies is higher when such sex-344 
linked pesticide resistance patterns are taken into account as the susceptibility of males (and 345 
developmental stages such as eggs) might slow down the resistance development process by reducing 346 
the overall population growth. 347 
Pyflubumide is structurally similar to the carboxamide fungicides that act as a complex II inhibitors 348 
(SDHI), and a similar mode of action has been documented (Furuya et al. 2017). Resistance to SDHI 349 
fungicides has been reported to be conferred by specific point mutations in complex II subunits (SDHB, 350 
-C, and -D) in many fungal plant pathogens (Avenot and Michailides 2010; Oliver 2014; Sierotzki and 351 
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Scalliet 2013). Because of the apparently frequent target-site resistance development in fungi, and the 352 
observed cross-resistance between pyflubumide, cyenopyrafen and cyflumetofen (all acting on complex 353 
II), we first searched for target-site resistance by sequencing all subunits (SDHA, until -D) that make up 354 
complex II. However, we did not find any target-site resistance mutation in subunits SDHB, SDHC and 355 
SDHD, previously implicated in QoI resistance in fungi (Avenot and Michailides 2010; Hahn 2014; 356 
Sierotzki and Scalliet 2013). The V209I variant in SDHA in JPR and JPR-R2 was not positioned in a 357 
conserved region and very likely not associated with resistance, as the ubiquinone-binding pocket where 358 
pyflubumide interacts is structurally defined by the interface between the SDHB, -C, and -D subunits 359 
(Sierotzki and Scalliet 2013), and is likely the reason why mutations in SDHA have not been uncovered 360 
in fungi yet.  This is in line with a previous study that did not find target-site resistance in the 361 
cyenopyrafen resistant strain JPR (Khalighi et al. 2016) and points toward an alternative mechanism of 362 
(cross)-resistance. 363 
Synergism experiments strongly suggested that cytochrome P450 monooxygenases and glutathione S-364 
transferases are involved in pyflubumide detoxification in female resistant mites in the two JPR-R strains 365 
(Table 3). To a lesser extent, this is also true for JPR (2-fold PBO synergism). A strong antagonism of 366 
toxicity was found after treatment with DEF, which confirms pyflubumide is a pro-acaricide that 367 
requires hydrolytic activation  (Khajehali et al. 2009; Nakano et al. 2015; Van Leeuwen et al. 2006). 368 
Interestingly, antagonism is much higher in JPR compared to both the susceptible LS-VL and resistant 369 
JPR-R strains, again pointing towards different mechanisms between parental and selected strains. 370 
Pretreatment with barbital dramatically lowered the resistance levels of JPR-R1-2 and JPR, whereas it 371 
slightly increased pyflubumide resistance in the susceptible strain LS-VL. This suggests that the 372 
detoxifying enzymes, most likely cytochrome P450s, were more suppressed than induced by barbital in 373 
the resistant strains. Collectively, it seems likely that the differences in pyflubumide susceptibility of 374 
eggs and males of the resistant strains might be due to a different detoxification potential. Higher levels 375 
of resistance in the JPR-R strains correlate with higher synergism ratio for PBO and DEM. 376 
Therefore, we performed a genome wide gene-expression analysis between parental (JPR) and selected 377 
resistant lines JPR-R. Transcriptome analysis did not show any notable differences between strains in 378 
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the absence of acaricide pressure (Fig. 2A-B).  In contrast, when JPO was used as the reference, over 379 
500 genes were differentially transcribed in JPR and JPR-R1-2 with the majority of the DEGs exhibiting 380 
stable transcript levels (Fig. 2C). Cluster analysis revealed a small group of DEGs that show an increased 381 
expression in JPR-R1-2, compared to JPO (Fig. 2C, cluster 3). The cytochrome P450 CYP392D4 is 382 
clustered in this group, and it belongs to the CYP392 family that underwent a spider mite-specific 383 
expansion (Grbić et al. 2011) and of which many members have been implicated in resistance in T. 384 
urticae (Demaeght et al. 2013a; Riga, M. et al. 2014; Van Leeuwen and Dermauw 2016). Together, 385 
these results suggest that the constitutive transcriptomic signature of pyflubumide resistance was already 386 
present in JPR and did not significantly change when selecting for higher resistance levels in JPR-R1-2 387 
(Fig. 2A). We therefore tested the hypothesis whether the high pyflubumide resistance of JPR-R1-2 388 
could be caused by a heritable increased plasticity (induction by pyflubumide). In our observations of 389 
the symptomology timing, the highest level of JPR-R responses to pyflubumide was observed 9 h after 390 
exposure to the acaricide. Afterwards, the symptoms declined, which suggests that the detoxifying 391 
mechanisms were activated after this time. We indeed found that five cytochrome P450s and four CCE 392 
genes were up-regulated when JPP-R1-2 were exposed to pyflubumide for 24 h, compared to water-393 
sprayed JPR-R1-2 mites. Here, the up-regulation of cytochrome P450s further supports our hypothesis 394 
that pyflubumide resistance is metabolic.  395 
Together, our results show that although many resistant T. urticae strains were susceptible to 396 
pyflubumide, there could be a risk of rapid development of pyflubumide resistance in the areas that have 397 
been exposed to cyenopyrafen and probably other complex II inhibitors. We gathered evidence that 398 
indicates that cytochrome P450 enzymes are likely involved in pyflubumide resistance. However, gene-399 
expression patterns have shown to be complex and failed to clearly identify which cytochrome P450(s) 400 
might be involved. Future work should focus on trying to get functional data on pyflubumide 401 
metabolizing enzymes and characterize resistance with alternative hypothesis-free approaches such as 402 
QTL mapping (Kurlovs et al. 2019). 403 
Acknowledgments 404 
16 
 
This work was partially funded by the University of Amsterdam (IBED), and it was supported by the 405 
Research Foundation - Flanders (FWO) [grant G009312N and grant G053815N] and the Research 406 
Council (ERC) under the European Union's Horizon 2020 research and innovation program [grant 407 
772026-POLYADAPT and 773902–SUPERPEST]. N.W. was supported by a Research Foundation - 408 
Flanders (FWO) post-doctoral fellowship (12T9818N).  409 
References 410 
Asahara M, Uesugi R, Osakabe M (2008) Linkage between one of the polygenic hexythiazox resistance 411 
genes and an etoxazole resistance gene in the two spotted spider mite (Acari: Tetranychidae). J Econ 412 
Entomol 101:1704-1710 413 
Avenot HF, Michailides TJ (2010) Progress in understanding molecular mechanisms and evolution of 414 
resistance to succinate dehydrogenase inhibiting (SDHI) fungicides in phytopathogenic fungi 29:643-415 
651 416 
Baker BS, Gorman M, Marin I (1994) Dosage compensation in Drosophila. Annu Rev Genet 28:491-417 
521 418 
Carrière Y (2003) Haplodiploidy, sex, and the evolution of pesticide resistance. J Econ Entomol 419 
96:1626-1640 420 
Daly JG, Fitt GP (1990) Monitoring for pyrethroid resistance in relation to body weight in adult 421 
Helicoverpa armigera (Hübner) (Lepidoptera: Noctuidae). J Econ Entomol 83:705-709 422 
Demaeght P, Dermauw W, Tsakireli D, Khajehali J, Nauen R, Tirry L, Vontas J, Lümmen P, Van 423 
Leeuwen T (2013a) Molecular analysis of resistance to acaricidal spirocyclic tetronic acids in 424 
Tetranychus urticae: CYP392E10 metabolizes spirodiclofen, but not its corresponding enol. Insect 425 
Biochem Mol Biol 43:544-554 426 
Demaeght P, Dermauw W, Tsakireli D, Khajehali J, Nauen R, Tirry L, Vontas J, Lümmen P, Van 427 
Leeuwen T (2013b) Molecular analysis of resistance to acaricidal spirocyclic tetronic acids in 428 
Tetranychus urticae: CYP392E10 metabolizes spirodiclofen, but not its corresponding enol. Insect 429 
Biochem Mol Biol 43:544-554 430 
Dermauw W, Wybouw N, Rombauts S, Menten B, Vontas J, Grbic M, Clark RM, Feyereisen R, Van 431 
Leeuwen T (2013) A link between host plant adaptation and pesticide resistance in the polyphagous 432 
spider mite Tetranychus urticae. Proc Natl Acad Sci U S A 110:E113-22 433 
Fotoukkiaii SM, Tan Z, Xue W, Wybouw N, Van Leeuwen T (2019) Identification and characterization 434 
of new mutations in mitochondrial cytochrome b that confer resistance to bifenazate and acequinocyl in 435 
the spider mite Tetranychus urticae. Pest Manag Sci https://doi.org/10.1002/ps.5628 436 
Furuya T, Machiya K, Fujioka S, Nakano M, Inagaki K (2017) Development of a novel acaricide, 437 
pyflubumide. J PESTIC SCI 42:132-136 438 
Furuya T, Suwa A, Nakano M, Fujioka S, Yasokawa N, Machiya K (2015) Synthesis and biological 439 
activity of a novel acaricide, pyflubumide. J PESTIC SCI D14-087 440 
17 
 
Grbić M, Van Leeuwen T, Clark RM, Rombauts S, Rouzé P, Grbić V, Osborne EJ, Dermauw W, Ngoc 441 
PCT, Ortego F (2011) The genome of Tetranychus urticae reveals herbivorous pest adaptations. Nature 442 
479:487 443 
Hahn M (2014) The rising threat of fungicide resistance in plant pathogenic fungi: Botrytis as a case 444 
study 7:133-141 445 
Jeppson L, Keifer H, Baker E (1975) Mites injurious to economic plants. (University of California Press: 446 
Los Angeles) 447 
Kauffmann A, Gentleman R, Huber W (2008) arrayQualityMetrics—a bioconductor package for quality 448 
assessment of microarray data. Bioinformatics 25:415-416 449 
Khajehali J, Van Nieuwenhuyse P, Demaeght P, Tirry L, Van Leeuwen T (2011) Acaricide resistance 450 
and resistance mechanisms in Tetranychus urticae populations from rose greenhouses in the 451 
Netherlands. Pest Manag Sci 67:1424-1433 452 
Khajehali J, Van Leeuwen T, Tirry L (2009) Susceptibility of an organophosphate resistant strain of the 453 
two-spotted spider mite (Tetranychus urticae) to mixtures of bifenazate with organophosphate and 454 
carbamate insecticides 49:185-192 455 
Khalighi M, Dermauw W, Wybouw N, Bajda S, Osakabe M, Tirry L, Van Leeuwen T (2016) Molecular 456 
analysis of cyenopyrafen resistance in the two‐spotted spider mite Tetranychus urticae. Pest Manag Sci 457 
72:103-112 458 
Khalighi M, Tirry L, Van Leeuwen T (2014) Cross‐resistance risk of the novel complex II inhibitors 459 
cyenopyrafen and cyflumetofen in resistant strains of the two‐spotted spider mite Tetranychus urticae. 460 
Pest Manag Sci 70:365-368 461 
Kurlovs AH, Snoeck S, Kosterlitz O, Van Leeuwen T, Clark RM (2019) Trait mapping in diverse 462 
arthropods by bulked segregant analysis 463 
Marín I, Siegal ML, Baker BS (2000) The evolution of dosage‐compensation mechanisms. Bioessays 464 
22:1106-1114 465 
Nakano M, Yasokawa N, Suwa A, Fujioka S, Furuya T, Sakata K (2015) Mode of action of novel 466 
acaricide pyflubumide: Effects on the mitochondrial respiratory chain. J PESTIC SCI  40:19-24 467 
Nauen R, Elbert A, McCaffery A, Slater R, Sparks TC (2012) IRAC: insecticide resistance, and mode 468 
of action classification of insecticides 1:935-955 469 
Oliver RP (2014) A reassessment of the risk of rust fungi developing resistance to fungicides. Pest 470 
Manag Sci 70:1641-1645 471 
Rao S, Padmaja M (1992) Mammalian-type dosage compensation mechanism in an insect—Gryllotalpa 472 
fossor (Scudder)—Orthoptera. J Biosci 17:253-273 473 
Rathman R, Johnson M, Rosenheim J, Tabashnik B, Purcell M (1992) Sexual differences in insecticide 474 
susceptibility and synergism with piperonyl butoxide in the leafminer parasitoid Diglyphus begini 475 
(Hymenoptera: Eulophidae). J Econ Entomol 85:15-20 476 
18 
 
Riga M, Tsakireli D, Ilias A, Morou E, Myridakis A, Stephanou E, Nauen R, Dermauw W, Van Leeuwen 477 
T, Paine M (2014) Abamectin is metabolized by CYP392A16, a cytochrome P450 associated with high 478 
levels of acaricide resistance in Tetranychus urticae. Insect Biochem Mol Biol 46:43-53 479 
Riga M, Bajda S, Themistokleous C, Papadaki S, Palzewicz M, Dermauw W, Vontas J, Van Leeuwen 480 
T (2017) The relative contribution of target-site mutations in complex acaricide resistant phenotypes as 481 
assessed by marker assisted backcrossing in Tetranychus urticae. Scientific reports 7:9202 482 
Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, Smyth GK (2007) A 483 
comparison of background correction methods for two-colour microarrays. Bioinformatics 23:2700-484 
2707 485 
Sierotzki H, Scalliet G (2013) A review of current knowledge of resistance aspects for the next-486 
generation succinate dehydrogenase inhibitor fungicides. Phytopathology 103:880-887 487 
Smyth Gordon K (2004) Linear Models and Empirical Bayes Methods for Assessing Differential 488 
Expression in Microarray Experiments 3:1 489 
Smyth GK, Altman NS (2013) Separate-channel analysis of two-channel microarrays: recovering inter-490 
spot information. BMC Bioinformatics 14:165 491 
Snoeck S, Wybouw N, Van Leeuwen T, Dermauw W (2018) Transcriptomic Plasticity in the Arthropod 492 
Generalist Tetranychus urticae Upon Long-Term Acclimation to Different Host Plants. G3 (Bethesda) 493 
8:3865-3879 494 
Stumpf N, Nauen R (2001) Cross-resistance, inheritance, and biochemistry of mitochondrial electron 495 
transport inhibitor-acaricide resistance in Tetranychus urticae (Acari: Tetranychidae). J Econ Entomol 496 
94:1577-1583 497 
Sugimoto N, Osakabe M (2014) Cross‐resistance between cyenopyrafen and pyridaben in the 498 
twospotted spider mite Tetranychus urticae (Acari: Tetranychidae). Pest Manag Sci 70:1090-1096 499 
Team RC (2018) R Foundation for Statistical Computing; Vienna, Austria: 2014:2013 500 
Tibshirani R, Walther G, Hastie T (2001) Estimating the number of clusters in a data set via the gap 501 
statistic 63:411-423 502 
Van Leeuwen T, Vanholme B, Van Pottelberge S, Van Nieuwenhuyse P, Nauen R, Tirry L, Denholm I 503 
(2008) Mitochondrial heteroplasmy and the evolution of insecticide resistance: non-Mendelian 504 
inheritance in action. Proc Natl Acad Sci U S A 105:5980-5985 505 
Van Leeuwen T, Dermauw W (2016) The molecular evolution of xenobiotic metabolism and resistance 506 
in chelicerate mites. Annu Rev Entomol 61:475-498 507 
Van Leeuwen T, Tirry L, Yamamoto A, Nauen R, Dermauw W (2015) The economic importance of 508 
acaricides in the control of phytophagous mites and an update on recent acaricide mode of action 509 
research. Pestic Biochem Physiol 121:12-21 510 
Van Leeuwen T, Vontas J, Tsagkarakou A, Dermauw W, Tirry L (2010) Acaricide resistance 511 
mechanisms in the two-spotted spider mite Tetranychus urticae and other important Acari: a review. 512 
Insect Biochem Mol Biol 40:563-572 513 
19 
 
Van Leeuwen T, Tirry L, Nauen R (2006) Complete maternal inheritance of bifenazate resistance in 514 
Tetranychus urticae Koch (Acari: Tetranychidae) and its implications in mode of action considerations. 515 
Insect Biochem Mol Biol 36:869-877 516 
Van Leeuwen T, Van Pottelberge S, Tirry L (2005) Comparative acaricide susceptibility and detoxifying 517 
enzyme activities in field‐collected resistant and susceptible strains of Tetranychus urticae 61:499-507 518 
Van Leeuwen T, Demaeght P, Osborne EJ, Dermauw W, Gohlke S, Nauen R, Grbic M, Tirry L, 519 
Merzendorfer H, Clark RM (2012) Population bulk segregant mapping uncovers resistance mutations 520 
and the mode of action of a chitin synthesis inhibitor in arthropods. Proc Natl Acad Sci U S A 109:4407-521 
4412 522 
Van Nieuwenhuyse P, Van Leeuwen T, Khajehali J, Vanholme B, Tirry L (2009) Mutations in the 523 
mitochondrial cytochrome b of Tetranychus urticae Koch (Acari: Tetranychidae) confer cross‐524 
resistance between bifenazate and acequinocyl Pest Manag Sci 65:404-412 525 
Van Pottelberge S, Van Leeuwen T, Khajehali J, Tirry L (2009) Genetic and biochemical analysis of a 526 
laboratory‐selected spirodiclofen‐resistant strain of Tetranychus urticae Koch (Acari: Tetranychidae) 527 
Pest Manag Sci 65:358-366 528 
Van Pottelberge S, Van Leeuwen T, Nauen R, Tirry L (2009) Resistance mechanisms to mitochondrial 529 
electron transport inhibitors in a field-collected strain of Tetranychus urticae Koch (Acari: 530 
Tetranychidae). Bull Entomol Res 99:23-31 531 
Van Pottelberge S, Van Leeuwen T, Van Amermaet K, Tirry L (2008) Induction of cytochrome P450 532 
monooxygenase activity in the two-spotted spider mite Tetranychus urticae and its influence on 533 
acaricide toxicity. Pestic Biochem Physiol 91:128-133 534 
Wybouw N, Kosterlitz O, Kurlovs AH, Bajda S, Greenhalgh R, Snoeck S, Bui H, Bryon A, Dermauw 535 
W, Van Leeuwen T, Clark RM (2019) Long-Term Population Studies Uncover the Genome Structure 536 
and Genetic Basis of Xenobiotic and Host Plant Adaptation in the Herbivore Tetranychus urticae. 537 
Genetics 211:1409-1427 538 
 539 
20 
 
Tables 540 
Table 1 The toxicity of pyflubumide (LC50 and slope) in a acaricide resistance reference panel of T. 541 
urticae 542 
 543 
Strain Resistant to Reference LC50 (mg/L) (95% CI)
a RR* 
LONDON Susceptible (Khajehali et al. 2011) 2.55 (2.46 - 2.63) 1 
WASATCH Susceptible (Riga et al. 2017) 3.08 (2.76 - 3.36) 1.21 
JPO Unknown (Sugimoto and Osakabe 2014,  Khalighi et al. 2016) 3.09 (2.87 - 3.28) 1.21 
JPS unknown (Asahara et al. 2008, Khalighi et al. 2016) 5.08 (4.88 - 5.28) 1.99 
LS-VL Susceptible (Van Leeuwen et al. 2005) 3.27 (3.04 - 3.43) 1.28 
BR-VL Bifenazate (Van Leeuwen et al. 2008) 1.83 (1.63 - 2.02) 0.72 
ETOXR Etoxazole (Van Leeuwen et al. 2012) 2.70 (2.52 - 2.86) 1.06 
TU008R Cyflumetofen (Khalighi et al. 2014) 3.18 (2.95 - 3.40) 1.25 
AKITA METIs (Stumpf and Nauen 2001) 4.20 (3.95 - 4.42) 1.65 
SR-VP Spirodiclofen (Demaeght et al. 2013b; Van Pottelberge et al. 2009) 4.30 (4.12 - 4.48) 1.69 
MAR-AB Multi (Dermauw et al. 2013) 5.86 (5.31 - 6.35) 2.30 
HOL3 Bifenazate (Van Nieuwenhuyse et al. 2009) 6.01 (5.58 - 6.43) 2.36 
MR-VL Multi (Van Leeuwen et al. 2005) 6.39 (5.80 - 6.85) 2.51 
MR-VP Multi (Dermauw et al. 2013; Van Pottelberge et al. 2009) 7.59 (6.80 - 8.24) 2.98 
JPR Cyenopyrafen (Khalighi et al. 2016) 49.07 (37.62 - 65.63) 19.24 
*Resistance ratio, LC50 of resistant strain/LC50 of susceptible strain 
aThe lethal concentration required to kill 50% of the population 
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Table 2 The toxicity of pyflubumide (LC50 and slope) in different life stages of susceptible and 544 
resistance T. urticae mites 545 
  WASATCH JP-R JP-RR1 JP-RR2 
 
Female 
LC50 (mg/ L)a 3.08 49.07 1437.48    1893.67 
(95% CI)b (2.76 - 3.36) (37.62 - 65.63) (1221.26 - 1666.77) (1641.63 - 2156.25) 
Slope ± SEc 8.69 ± 0.86 2.15 ± 0.21 2.08 ± 0.20 2.20 ± 0.21 
RR* - 15.93 466.71 614.83 
 
Male 
LC50 (mg/ L)a 0.44 2.98 8.13  5.72 
(95% CI)b (0.40 ± 0.48) (2.73 ± 3.19) (7.41 ± 8.79) (4.97 ± 6.34) 
Slope ± SEc 4.83 ± 0.5 5.03 ± 0.42 4.55± 0.41 3.59 ± 0.42 
RR* - 6.77 18.48 13 
 
Egg 
LC50 (mg/ L)a 23.6 318.20 98.19  54.10  
(95% CI)b (19.93 ± 27.60) (258.37 ± 381.99) (78.71 ± 118.97) (40.07 ± 68.91) 
Slope ± SEc 2.03 ± 0.14 1.60 ± 0.15 1.61 ± 0.12 1.42 ± 0.11 
RR* - 13.48 4.16 2.29 
aThe lethal concentration required to kill 50% of the population 
 bConfdence interval to 95% of the LC estimates 
CStandard error 
*Resistance ratio, LC50 of resistant strain/LC50 of susceptible strain 
 
 546 
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Table 3 The effect of synergist/ antagonist PBO, DEF, DEM and barbital on pyflubumide toxicity in 547 
susceptible and resistant strains of T. urticae 548 
  LS-VL JP-R JP-RR1 JP-RR2 
Acaricide alone LC50 (mg/ L)
a 
(95%CI)b  
Slope ± SEc 
3.27 
(3.10 - 3.41) 
11.11 ± 0.92 
49.07 
(37.62 - 65.63) 
2.15 ± 0.21 
1437.48    
(1221.26 - 1666.77) 
2.08 ± 0.20 
1893.67    
 (1641.63 - 2156.25) 
2.20 ± 0.21 
 
PBO 
LC50 (mg/ L)
a 
(95%CI)b  
Slope ± SEc 
SRd 
2.74 
(2.59 - 2.85) 
10.40 ± 1.10 
1.2 
22.82 
(19.31 - 26.71) 
1.99 ± 0.17 
2.15 
92.79 
(81.01 - 104.85) 
2.62 ± 0.19 
15.49 
69.21 
(55.66 - 84.41) 
1.69 ± 0.14 
20.4 
 
DEF 
LC50 (mg/ L)
a 
(95%CI)b  
Slope ± SEc 
SRd 
7.38 
(6.86 - 7.79) 
7.55 ± 0.86 
0.44 
2176.16 
(1834.28 - 2498.45) 
2.23 ± 0.22 
0.02 
3843.95 
(3285.81 - 4524.38) 
2.08 ± 0.24 
0.37 
5028.17 
(4245.05 - 6011.25) 
1.89 ± 0.24 
0.38 
 
DEM 
LC50 (mg/ L)
a 
(95%CI)b 
Slope ± SEc 
SRd 
2.36 
(2.26 - 2.46) 
6.95 ± 0.58 
1.38 
21.90 
(16.00 - 28.92) 
1.08 ± 0.15 
2.24 
152.30  
(130.05 - 176.97) 
1.59 ± 0.11 
 9.44 
73.73  
(58.33 - 91.05) 
1.56 ± 0.10  
25.68 
 
Barbital 
LC50 (mg/ L)
a 
(95%CI)b  
Slope ± SEc 
BAR Ratiof 
5.50  
(4.90 - 5.99) 
4.54 ± 0.57 
1.68 
8.93 
(6.88 - 11.26) 
1.77 ± 0.15 
0.18 
17.56  
(14.39 - 20.94) 
2.14 ± 0.18  
0.01 
32.61  
(27.98 - 37.56) 
2.31 ± 0.17  
0.02 
aThe lethal concentration required to kill 50% of the population 
bConfdence interval to 95% of the LC estimates 
CStandard error 
dSynergism ratio, LC50 of acaricide alone/LC50 obtained after synergist pretreatment 
 f Barbital ratio, LC50 of induced population/LC50 of non-induced population 
549 
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Fig. Legends 550 
Fig. 1 Dose-response relationships of pyflubumide toxicity on JPO, and the pyflubumide selected 551 
strains. JPO is susceptible to complex II acaricides, and was first used in selection experiments. JPO 552 
was selected with cyenopyrafen  resulting in JPR (Khalighi et al. 2016) and developed low to moderate 553 
cross-resistance to pyflubumide. From JPR, two selection lines (JPR-R1 and JPR-R2) were established 554 
by pyflubumide selection. SEL1 and SEL2 was the first and second generation of selection that finally 555 
generated the JPR-R1 strain. JPRR-R2 as selected out of JPR on plants as described in M&M. 556 
Fig. 2 The constitutive transcriptomic changes between JPO, JPR, JPR-R1, and JPR-R2. Panel 557 
A: PCA plot of JPO, JPR, JPR-R1, and JPR-R2. The four samples of each strain are separately plotted. 558 
Panel B: Scatterplot of the differentially expressed genes in the two pyflubumide-resistant strains JPR-559 
R1 and JPR-R2 versus ancestral JPR. Only the genes with an FDR-corrected p-value of < 0.05 and 560 
log2FC ≥ 1 were regarded as differentially expressed. Only one cytochrome P450 was differentially 561 
transcribed in both pyflubumide-resistant strains, was down-regulated, and coded for CYP392A12. In 562 
panel B: Venn-diagram showing the overlap of differentially expressed genes in JPR-R1 and JPR-R2 563 
versus ancestral JPR. Panel C: Using JPO as the common reference, the transcriptional patterns of the 564 
three k-clustered groups of the 560 DEGs across JPR, JPR-R2, and JPR-R1 are plotted. Circles represent 565 
the average (±SD) of gene-expression in each strain (color coded) 566 
Fig. 3 Timing of symptomology in T. urticae strains JPR, JPR-R1, and JPR-R2. Percentage of mites 567 
that showed the symptoms of poisoning caused by pyflubumide treatment over 24 hours time course 568 
after spraying. Symptoms include death, inability to walk, or uncoordinated behavior (spastic 569 
movement) after a gentle touch by a tiny brush 570 
Fig. 4 The plastic transcriptomic changes upon 9 and 24 hours of exposure to a sub-lethal dose of 571 
pyflubumide. Panel A: PCA plot of the individual samples alongside PC1 and PC2 (55.5% of total data 572 
variation) that were collected to investigate plastic transcriptomic responses. Panel B: Above, venn-573 
diagram showing the overlap of differentially expressed genes in JPR-R1 and JPR-R2 after 24 h 574 
exposure to 100 mg/L pyflubumide. Below, scatterplot of the 109 shared differentially expressed genes 575 
in JPR-R1 and JPR-R2 exposed for 24 h to 100 mg/L pyflubumide. Genes that code for cytochrome 576 
24 
 
P450s are depicted by black circles and labelled with their CYP identifier. Only the genes with an FDR-577 
corrected p-value of < 0.05 and log2FC ≥ 1 were regarded as differentially expressed 578 
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